(Q38693445)

English

Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

systematic review

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Ichiro Yasue

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Shinji Matsunaga

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Taro Kishi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Kiyoshi Fujita

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

1 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Journal of Alzheimer's Disease

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

733-740

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

A review of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

The prevalence of Parkinson's disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Atypical antipsychotics in Parkinson-sensitive populations

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Psychiatric aspects of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Serotonin 2A receptors and visual hallucinations in Parkinson disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

On the discovery and development of pimavanserin: a novel drug candidate for Parkinson's psychosis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

A comparison of the pharmacokinetics of oral and sublingual cyproheptadine

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

5-HT2A receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Association between the use of serotonin receptor 2A-blocking antidepressants and joint disorders

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

5-HT(2A) inverse-agonists for the treatment of insomnia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Mirtazapine improves visual hallucinations in Parkinson's disease: a case report

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Identifiers

10.3233/JAD-150818

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

release_l7ovl7s6fffv3b3diqj4twnfoa

1 reference

https://api.fatcat.wiki/v0/release/l7ovl7s6fffv3b3diqj4twnfoa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38693445&oldid=1842933540"